AXA S.A. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
AXA S.A. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$13,606,000
-67.9%
79,059
-76.6%
0.04%
-37.7%
Q2 2021$42,416,000
+70.6%
338,010
+84.4%
0.06%
-19.7%
Q1 2021$24,858,000
-15.9%
183,300
-20.6%
0.08%
-18.3%
Q4 2020$29,543,000
+9.1%
230,914
-4.0%
0.09%
-5.1%
Q3 2020$27,081,000
-41.8%
240,657
-50.7%
0.10%
+6.5%
Q2 2020$46,552,000
+24.1%
488,630
+17.0%
0.09%
-2.1%
Q1 2020$37,526,000
+38.8%
417,570
-18.1%
0.09%
+70.9%
Q4 2019$27,034,000
-6.5%
509,870
-30.4%
0.06%
-5.2%
Q3 2019$28,926,000
-5.1%
732,104
-1.3%
0.06%
-3.3%
Q2 2019$30,478,000
+117.9%
741,910
+147.0%
0.06%
+9.1%
Q1 2019$13,986,000
+367.3%
300,314
+336.9%
0.06%
+323.1%
Q4 2018$2,993,000
+33.3%
68,735
+75.3%
0.01%
+62.5%
Q3 2018$2,245,000
-64.4%
39,220
-69.8%
0.01%
-66.7%
Q2 2018$6,310,000
-30.9%
130,055
-44.3%
0.02%
-33.3%
Q1 2018$9,130,000
-20.0%
233,504
-13.1%
0.04%
-20.0%
Q4 2017$11,409,000
+13.6%
268,815
-0.1%
0.04%
+4.7%
Q3 2017$10,043,000
+2.1%
269,092
-16.8%
0.04%
-4.4%
Q2 2017$9,833,000323,5550.04%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders